Mechanisms of type 1 diabetic serum-induced hyperactivation of CaV1 channels in the pancreatic β cell
Author: Shi, Yue
Date: 2016-02-26
Location: Leksellsalen, T3:02, Eugeniahemmet, Karolinska Universitetssjukhuset, Solna
Time: 09.00
Department: Inst för molekylär medicin och kirurgi / Dept of Molecular Medicine and Surgery
Abstract
The pancreatic β cell relies on appropriate Ca2+ entry through voltage-gated calcium (CaV)
channels to accomplish its unique function insulin secretion and to guarantee its viability.
Well-regulated β cell CaV channels are critical to ensure adequate functional β cell mass,
thereby maintaining adequate insulin release and glucose homeostasis in the body. When β
cell CaV channels mediate insufficient or excessive Ca2+ influx due to either inherited or
acquired defects, β cell becomes malfunctioning and even dies. Type 1 diabetic (T1D)
serum hyperactivates β cell CaV1 channels driving Ca2+-dependent β cell apoptosis via
previously unappreciated mechanisms. The present PhD work has mechanistically dissected
T1D serum-induced hyperactivation of CaV1 channels in the β cell by combining patchclamp
techniques, confocal microscopy, as well as molecular and cellular approaches. It
reveals the following findings:
Functional CaV1.3 channels reside in 20 % of mouse islet CaV1.2-/- β cells. They characteristically show a large unitary Ba2+ conductance with long-lasting openings in plasma membrane patches of islet cells endowed with undetectable voltage-gated Na+ currents, larger cell capacitance (> 7 pF) and insulin mRNA. These observations pinpoint β cell-specific CaV1.2-/- mice as a convenient small animal model for investigation of human β cell CaV1.3 channel-related disorders such as T1D serum-induced hyperactivation of β cell CaV1.3 channels.
T1D serum hyperactivates both CaV1.2 and CaV1.3 channels by elevating their conductivity and number in the β cell plasma membrane. This finding emphasizes that both CaV1.2 and CaV1.3 channels are potential druggable targets for prevention of Ca2+ overload-induced β cell death.
Apolipoprotein CIII (ApoCIII) in T1D serum is electrophysiologically validated to be the actual factor enhancing CaV channel currents in the β cell. This validation opens up the possibility to deplete or neutralize ApoCIII in T1D serum for medical intervention of CaV channel hyperactivation-driven β cell destruction.
ApoCIII activates both PKA and Src kinase in a scavenger receptor class B type I/β1 integrin-dependent fashion to selectively hyperactivate β cell CaV1 channels without altering β cell CaV1 channel expression. ApoCIII-induced hyperactivation of β cell CaV1 channels results from the enriched density and increased activity of functional CaV1 channels in the β cell plasma membrane. This newly-identified signaling pathway shows great potential as a set of novel druggable targets for prevention of Ca2+-dependent β cell death in association with diabetes.
The key endocytic protein syndapin I/PACSIN 1 (PCS1) is richly expressed in β cells to govern endocytic activity. PCS1-mediated endocytosis acts as a homeostatic control system to fine-tune the CaV1 channel density in the β cell plasma membrane. These findings add a new layer of complexity to the mechanisms of β cell CaV1 channel regulation.
ApoCIII impairs both constitutive and regulated β cell endocytosis with no influence on PCS1 expression. Consequently, ApoCIII abrogates PCS1-dependent endocytic trafficking, thereby accumulating excessive CaV1 channels in the β cell plasma membrane. These results delineate a novel mechanism of Ca2+-dependent β cell destruction in diabetes development and reveal a promising and attractive option to counteract the critical diabetogenic process of Ca2+-dependent β cell death.
Overall, the aforementioned findings depict a mechanistic picture of how ApoCIII renders CaV1 channels highly enriched and excessively activated in the β cell plasma membrane, thereby resulting in pathologically exaggerated Ca2+ influx and Ca2+-dependent β death. These findings lay the foundation for novel treatment strategies for diabetes.
Functional CaV1.3 channels reside in 20 % of mouse islet CaV1.2-/- β cells. They characteristically show a large unitary Ba2+ conductance with long-lasting openings in plasma membrane patches of islet cells endowed with undetectable voltage-gated Na+ currents, larger cell capacitance (> 7 pF) and insulin mRNA. These observations pinpoint β cell-specific CaV1.2-/- mice as a convenient small animal model for investigation of human β cell CaV1.3 channel-related disorders such as T1D serum-induced hyperactivation of β cell CaV1.3 channels.
T1D serum hyperactivates both CaV1.2 and CaV1.3 channels by elevating their conductivity and number in the β cell plasma membrane. This finding emphasizes that both CaV1.2 and CaV1.3 channels are potential druggable targets for prevention of Ca2+ overload-induced β cell death.
Apolipoprotein CIII (ApoCIII) in T1D serum is electrophysiologically validated to be the actual factor enhancing CaV channel currents in the β cell. This validation opens up the possibility to deplete or neutralize ApoCIII in T1D serum for medical intervention of CaV channel hyperactivation-driven β cell destruction.
ApoCIII activates both PKA and Src kinase in a scavenger receptor class B type I/β1 integrin-dependent fashion to selectively hyperactivate β cell CaV1 channels without altering β cell CaV1 channel expression. ApoCIII-induced hyperactivation of β cell CaV1 channels results from the enriched density and increased activity of functional CaV1 channels in the β cell plasma membrane. This newly-identified signaling pathway shows great potential as a set of novel druggable targets for prevention of Ca2+-dependent β cell death in association with diabetes.
The key endocytic protein syndapin I/PACSIN 1 (PCS1) is richly expressed in β cells to govern endocytic activity. PCS1-mediated endocytosis acts as a homeostatic control system to fine-tune the CaV1 channel density in the β cell plasma membrane. These findings add a new layer of complexity to the mechanisms of β cell CaV1 channel regulation.
ApoCIII impairs both constitutive and regulated β cell endocytosis with no influence on PCS1 expression. Consequently, ApoCIII abrogates PCS1-dependent endocytic trafficking, thereby accumulating excessive CaV1 channels in the β cell plasma membrane. These results delineate a novel mechanism of Ca2+-dependent β cell destruction in diabetes development and reveal a promising and attractive option to counteract the critical diabetogenic process of Ca2+-dependent β cell death.
Overall, the aforementioned findings depict a mechanistic picture of how ApoCIII renders CaV1 channels highly enriched and excessively activated in the β cell plasma membrane, thereby resulting in pathologically exaggerated Ca2+ influx and Ca2+-dependent β death. These findings lay the foundation for novel treatment strategies for diabetes.
List of papers:
I. Guang Yang, Yue Shi, Jia Yu, Yuxin Li, Lina Yu, Andrea Welling, Franz Hofmann, Jörg Striessnig, Lisa Juntti-Berggren, Per-Olof Berggren, Shao-Nian Yang (2015) CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. Cell Mol Life Sci 72: 1197-1207.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Yue Shi, Guang Yang, Jia Yu, Lina Yu, Ruth Westenbroek, William A. Catterall, Lisa Juntti-Berggren, Per-Olof Berggren, Shao-Nian Yang (2014) Apolipoprotein CIII hyperactivates β cell CaV1 channels through SR-BI/β1 integrin-dependent coactivation of PKA and Src. Cell Mol Life Sci 71: 1289-1303.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Yue Shi, Guang Yang, Jia Yu, Yuxin Li, Britta Qualmann, Michael M. Kessels, Lina Yu, Per-Olof Berggren, Shao-Nian Yang (2015) Inositol hexakisphosphate primes syndapin I/PACSIN 1 activation in endocytosis. [Manuscript]
IV. Yue Shi, Guang Yang, Jia Yu, Lina Yu, Lisa Juntti-Berggren, Per-Olof Berggren, Shao-Nian Yang (2015) Apolipoprotein CIII accumulates CaV1 channels in the β cell plasma membrane via abrogation of syndapin I/PACSIN 1-dependent endocytic trafficking. [Manuscript]
I. Guang Yang, Yue Shi, Jia Yu, Yuxin Li, Lina Yu, Andrea Welling, Franz Hofmann, Jörg Striessnig, Lisa Juntti-Berggren, Per-Olof Berggren, Shao-Nian Yang (2015) CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. Cell Mol Life Sci 72: 1197-1207.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Yue Shi, Guang Yang, Jia Yu, Lina Yu, Ruth Westenbroek, William A. Catterall, Lisa Juntti-Berggren, Per-Olof Berggren, Shao-Nian Yang (2014) Apolipoprotein CIII hyperactivates β cell CaV1 channels through SR-BI/β1 integrin-dependent coactivation of PKA and Src. Cell Mol Life Sci 71: 1289-1303.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Yue Shi, Guang Yang, Jia Yu, Yuxin Li, Britta Qualmann, Michael M. Kessels, Lina Yu, Per-Olof Berggren, Shao-Nian Yang (2015) Inositol hexakisphosphate primes syndapin I/PACSIN 1 activation in endocytosis. [Manuscript]
IV. Yue Shi, Guang Yang, Jia Yu, Lina Yu, Lisa Juntti-Berggren, Per-Olof Berggren, Shao-Nian Yang (2015) Apolipoprotein CIII accumulates CaV1 channels in the β cell plasma membrane via abrogation of syndapin I/PACSIN 1-dependent endocytic trafficking. [Manuscript]
Institution: Karolinska Institutet
Supervisor: Yang, Shao-Nian
Issue date: 2016-01-28
Rights:
Publication year: 2016
ISBN: 978-91-7676-190-8
Statistics
Total Visits
Views | |
---|---|
Mechanisms ...(legacy) | 522 |
Mechanisms ... | 206 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Mechanisms ... | 2 | 3 | 3 | 0 | 3 | 3 | 0 |
File Visits
Views | |
---|---|
Thesis_Yue_Shi.pdf | 410 |
Thesis_Yue_Shi.pdf(legacy) | 370 |
Spikblad_Yue_Shi.pdf(legacy) | 71 |
Spikblad_Yue_Shi.pdf | 32 |
Top country views
Views | |
---|---|
Sweden | 172 |
United States | 144 |
Germany | 84 |
China | 37 |
South Korea | 31 |
United Kingdom | 10 |
Poland | 10 |
France | 7 |
Ireland | 7 |
Finland | 6 |
Top cities views
Views | |
---|---|
Ashburn | 70 |
Stockholm | 42 |
Seoul | 29 |
Kiez | 27 |
Degerfors | 20 |
Beijing | 13 |
Woodbridge | 10 |
Wilmington | 9 |
Kraków | 8 |
Dublin | 7 |